BRAF V600E
specificA change in the amino acid residue at position 600 in the serine/threonine protein kinase B-raf protein where valine has been replaced by glutamic acid.
10
Centers
8
Active Trials
$12M
Cancer Funding
Top Centers for BRAF V600E(10)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive High-Volume Research Center | 77.0 |
| 2 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 68.2 |
| 3 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 64.8 |
| 4 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 55.0 |
| 5 | NCI Comprehensive Active Research Program | 51.5 |
| 6 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 50.8 |
| 7 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program | 50.8 |
| 8 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 50.8 |
| 9 | Boston University Cancer CenterBoston, MA Active Research Program | 50.8 |
| 10 | NCI Comprehensive | 30.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →